Page last updated: 2024-08-24

erdosteine and albuterol

erdosteine has been researched along with albuterol in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Bovio, C; Braga, PC; Culici, M; Dal Sasso, M; Fonti, E	1
Bertacco, S; Dal Negro, R; Micheletto, C; Tognella, S; Trevisan, F; Visconti, M	1
Dal Negro, RW; Turco, P; Visconti, M	1

Trials

2 trial(s) available for erdosteine and albuterol

Article	Year
Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD. Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5 Topics: Adrenergic beta-Agonists; Aged; Albuterol; Bronchi; Drug Synergism; Expectorants; Female; Forced Expiratory Volume; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes	2008
Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial. Pulmonary pharmacology & therapeutics, 2015, Volume: 33 Topics: Administration, Oral; Adult; Aged; Albuterol; Antioxidants; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Expectorants; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes	2015

Article

Year

Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.

Therapeutic advances in respiratory disease, 2008, Volume: 2, Issue:5

Topics: Adrenergic beta-Agonists; Aged; Albuterol; Bronchi; Drug Synergism; Expectorants; Female; Forced Expiratory Volume; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes

2008

Efficacy of erdosteine 900 versus 600 mg/day in reducing oxidative stress in patients with COPD exacerbations: Results of a double blind, placebo-controlled trial.

Pulmonary pharmacology & therapeutics, 2015, Volume: 33

Topics: Administration, Oral; Adult; Aged; Albuterol; Antioxidants; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Expectorants; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Thioglycolates; Thiophenes

2015

Other Studies

2 other study(ies) available for erdosteine and albuterol

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophils. Drugs under experimental and clinical research, 2002, Volume: 28, Issue:4 Topics: Albuterol; Drug Synergism; Expectorants; Humans; Neutrophils; Respiratory Burst; Thioglycolates; Thiophenes	2002